MedPath

THE CLINICAL TRIAL TO STUDY THE EFFECT OF THE DRUG SHANMUGA CHOORANAM IN PATIENTS HAVING GASTRIC REGURGITATIO

Phase 2
Conditions
Health Condition 1: K92- Other diseases of digestive system
Registration Number
CTRI/2018/12/016563
Lead Sponsor
GOVERNMENT SIDDHA MEDICAL COLLEGE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

LOSS OF APPETITE

DYSPHAGIA

HEART BURN DUE TO INDIGESTION

REGURGITATIO

Exclusion Criteria

HIATUS HERNIA

CHOLELITHIASIS

PYLORIC STENOSIS

ESOPHAGEAL CARCINOMA

HELICOBACTER PYLORI

ESOPHAGEAL CARCINOMA

PREGNANT WOMEN

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
OUTCOME IS MAINLY ASSESSED BY REDUCTION IN CLINICAL SYMPTOMS AND BY COMPARING THE INVESTIGATIONAL PARAMETERS BEFORE AND AFTER TREATMENTTimepoint: OUTCOME IS MAINLY ASSESSED BY REDUCTION IN CLINICAL SYMPTOMS AND BY COMPARING THE INVESTIGATIONAL PARAMETERS BEFORE AND AFTER TREATMENT
Secondary Outcome Measures
NameTimeMethod
ILTimepoint: NI
© Copyright 2025. All Rights Reserved by MedPath